GlaxoSmithKline (GSK) Posts Improved Q4 EPS of 32.6p; Revs Ease

Article Related Articles (1) Stock Quotes (1) Comments (0)

GlaxoSmithKline (NYSE: GSK) reported Q4 EPS of 32.6p, versus 31.2p reported last year. Revenue for the quarter came in at GBP6.8 billion, versus GBP6.98 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
• China Hydroelectric (CHC) Reports Break Even Q1 Loss
• Crown Crafts, Inc. (CRWS) Posts Flat Q4 EPS of 19c

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?